Document Detail


Hepatic peptidyl prolyl hydroxylase activity and liver fibrosis--a prospective study of 94 infants and children with hepatobiliary disorders.
MedLine Citation:
PMID:  6327486     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To assess whether hepatic peptidyl prolyl hydroxylase (PPH) activity could serve as a practical quantitative indicator of hepatic fibrosis or aid in the categorization, diagnosis or prognosis of hepatobiliary disorders in infancy and childhood, the activity of this enzyme has been determined prospectively by a tritium release method in 97 biopsies from 94 infants and children with the following conditions: acute hepatitis of infancy, 10 patients; extrahepatic biliary atresia, 13; previous hepatitis of infancy, 8; alpha-1-antitrypsin deficiency, 6; chronic active hepatitis, 17; chronic persistent hepatitis, 5; glycogen storage disease, 5; and 25 patients with a miscellanea of other liver disorders. PPH activity was considered in relation to diagnosis, biochemical and histological abnormality and subsequent prognosis over a 4-year period. Five liver biopsies which showed no histological abnormality were considered as "controls" having PPH values of 0.72 +/- 0.47 (mean +/- S.D.). PPH activity was significantly elevated in acute hepatitis of infancy, 9 of the 10 infants having PPH greater than 1.66 units (i.e., mean +/- 2 S.D. of the "control" value). Nine infants (70%) with extrahepatic biliary atresia also had PPH activity above this value, as did two with alpha-1-antitrypsin deficiency and 12 patients all in different diagnostic categories. PPH activity did not correlate with hepatic fibrosis as indicated by hepatic hydroxyproline concentration or by histological assessment, or with biochemical tests of liver function within any diagnostic group or in the series as a whole. PPH activity was similar in biopsies with and without histological features of cirrhosis.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
P Trivedi; M S Tanner; B Portmann; J McClement; A P Mowat
Related Documents :
20186066 - Galectin-3-binding protein: a serological and histological assessment in accordance wit...
18471546 - Diagnosis and quantitation of fibrosis.
17705266 - Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the p...
16970596 - Diagnostic accuracy of a fibrosis serum panel (fibrospect ii) compared with knodell and...
19014656 - Hiv prevention: what have we learned from community experiences in concentrated epidemics?
25296096 - "if i take my medicine, i will be strong: " evaluation of a pediatric hiv disclosure in...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Hepatology (Baltimore, Md.)     Volume:  4     ISSN:  0270-9139     ISO Abbreviation:  Hepatology     Publication Date:    1984 May-Jun
Date Detail:
Created Date:  1984-07-13     Completed Date:  1984-07-13     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8302946     Medline TA:  Hepatology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  436-41     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Bile Ducts / abnormalities*
Biopsy
Child
Child, Preschool
Cholestasis, Intrahepatic / enzymology
Collagen / analysis
Female
Hepatitis / enzymology
Humans
Infant
Liver / enzymology*
Liver Cirrhosis / enzymology
Liver Diseases / enzymology*
Liver Neoplasms / enzymology
Male
Procollagen-Proline Dioxygenase / analysis*
Prognosis
Prospective Studies
alpha 1-Antitrypsin Deficiency
Chemical
Reg. No./Substance:
9007-34-5/Collagen; EC 1.14.11.2/Procollagen-Proline Dioxygenase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Liver disease in cytomegalovirus mononucleosis: a light microscopical and immunoperoxidase study of ...
Next Document:  Assessment of beta-adrenergic blockade with propranolol in patients with cirrhosis.